The HE staining results confirmed the difference in tumor growth among the groups, while staining of CANX, MAP1LC3B, MKI67, and cleaved Caspase 3 confirmed that ND could enhance chemotherapy sensitivity in vivo by reducing the expression of CANX (Figure 11D-H, Figure S10 I-L). The gene discussed is CANX; the disease is neoplasm.